Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001010207-10-000044
Filing Date
2010-02-16
Accepted
2010-02-16 16:45:09
Documents
1
Group Members
BRIAN J. STARK

Document Format Files

Seq Description Document Type Size
1 OPEXA THERAPEUTICS, INC. SCHEDULE 13G.A.4 sch13ga4opxa2010216.txt SC 13G/A 9387
  Complete submission text file 0001010207-10-000044.txt   11461
Mailing Address 3600 SOUTH LAKE DRIVE ST. FRANCIS WI 53235
Business Address
Roth Michael Anthony (Filed by) CIK: 0001010207 (see all company filings)

Type: SC 13G/A

Mailing Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381
Business Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Subject) CIK: 0001069308 (see all company filings)

EIN.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81104 | Film No.: 10608869
SIC: 2834 Pharmaceutical Preparations